- ►endojournals.org B Laferrere, J Teixeira, J McGinty, H Tran, … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Context: Gastric bypass surgery (GBP) results in rapid weight loss, improvement
of type 2 diabetes (T2DM), and increase in incretins levels. Diet-induced weight
loss also improves T2DM and may increase incretin levels. Cited by 56 - Related articles - All 6 versions
- ►endojournals.org CW Chia, JM Egan - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Evidence Synthesis: Exenatide and liraglutide are injection based. Three-year
follow-up data on exenatide showed a sustained weight loss and glycosylated
hemoglobin (HbA 1c ) reduction of 1%. Nausea and vomiting are common. ... Cited by 22 - Related articles - All 5 versions
O Schmitz - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc The pandemic explosion of type 2 diabetes incidence is well established, due to
dramatic global changes in lifestyle over the past few decades and in the
foreseeable future. To alter the course of this trend may take, at best, up ... Cited by 2 - Related articles - BL Direct - All 2 versions
- ►endojournals.org [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2008 - Endocrine Soc Page 1. 1 Acute DPP-4 Inhibition rapidly Enhances Insulin-mediated
Suppression of Endogenous Glucose Production in Mice Hélène ... Cited by 1 - Related articles
JA Koehler, LL Baggio, BJ Lamont, S Ali, DJ … - Diabetes, 2009 - glucagon.com Page 1. GLP-1 and experimental murine pancreatitis GLP-1 receptor activation
modulates pancreatitis-associated gene expression but ... Cited by 1 - Related articles - View as HTML - All 4 versions
KS Lim, JR Kim, YJ Choi, KH Shin, KP Kim, … - Clinical therapeutics, 2008 - Elsevier Methods: A dose—block-randomized, double-blind, placebo-controlled, ascending
single-dose, Phase I study was performed in healthy Korean male subjects
assigned to receive 25, 50, 100, 200, 400, or 600 mg of LC15-0444 capsules. ... Cited by 1 - Related articles - All 5 versions
- ►glucagon.com [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2009 - Endocrine Soc Pharmacological approaches that enhance incretin action for the treatment of
type 2 diabetes mellitus have recently been developed, ie. injectable
glucagon-like peptide-1 receptor (GLP-1R) agonists with prolonged plasma ... Related articles - All 3 versions
H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - glucagon.com Page 1. 1 Acute DPP-4 Inhibition rapidly Enhances Insulin-mediated
Suppression of Endogenous Glucose Production in Mice Hélène ... Related articles - View as HTML
- ►wdc-jp.com [PDF] Y Kirino, T Kamimoto, Y Sato, K Kawazoe, K … - Biological & pharmaceutical bulletin, 2009 - J-STAGE IV has been recognized to play an important role in the cleavage and
inactivation of biologically active peptides with penultimate L -proline or L
-alanine at the N-terminus, such as glucagon-like peptide 1 (GLP-1) and ... Cited by 1 - Related articles - All 6 versions
[CITATION] Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 …
J Jendle, MA Nauck, DR Matthews, A Frid, K … - Diabetes, Obesity and Metabolism, 2009 - Blackwell Publishing Ltd
